Cargando…

The Correlation between Time in Range and Diabetic Microvascular Complications Utilizing Information Management Platform

BACKGROUND: In recent years, the time of blood glucose within the target range is a new research hotspot in blood glucose management. TIR is expected to be a novel indicator for evaluating the efficacy of glycemic control and predicting diabetic complications. However, its relationship with diabetic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheng, Xia, Xiong, Guo-Hui, Yu, Peng-Fei, Liu, Jian-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755494/ https://www.ncbi.nlm.nih.gov/pubmed/33381172 http://dx.doi.org/10.1155/2020/8879085

Ejemplares similares

Diabetic Microvascular Complications
por: Migdalis, I., et al.
Publicado: (2018)

Time in range, as measured by continuous glucose monitor, as a predictor of microvascular complications in type 2 diabetes: a systematic review
por: Raj, Rishi, et al.
Publicado: (2022)

Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes
por: Hirsch, Irl B., et al.
Publicado: (2019)

Red blood cell count as an indicator of microvascular complications in Chinese patients with type 2 diabetes mellitus
por: Wang, Zhan-Sheng, et al.
Publicado: (2013)

The Correlation of the Neutrophil-to-Lymphocyte Ratio With Microvascular Complications in Patients With Diabetes Mellitus
por: Mahajan, Mayank, et al.
Publicado: (2023)

Vaccinium as Potential Therapy for Diabetes and Microvascular Complications
por: Huang, Hui, et al.
Publicado: (2023)

Correlations among Diabetic Microvascular Complications: A Systematic Review and Meta-analysis
por: Li, Jianqing, et al.
Publicado: (2019)

Inflammation and diabetic retinal microvascular complications
por: Zhang, Wenbo, et al.
Publicado: (2011)

Inflammation in the pathogenesis of microvascular complications in diabetes
por: Nguyen, Dung V., et al.
Publicado: (2012)

MicroRNA and Microvascular Complications of Diabetes
por: Barutta, F., et al.
Publicado: (2018)

The Role of Biofactors in Diabetic Microvascular Complications
por: Ziegler, Dan, et al.
Publicado: (2022)

Genetics of diabetes-associated microvascular complications
por: Lyssenko, Valeriya, et al.
Publicado: (2023)

Prevalence of Hand Disorders in Type 2 Diabetes Mellitus and its Correlation with Microvascular Complications
por: Pandey, A, et al.
Publicado: (2013)

The Ubiquitin-Proteasome System and Microvascular Complications of Diabetes
por: Yadranji Aghdam, Saeed, et al.
Publicado: (2013)

Is cognitive impairment the fourth diabetic microvascular complication?
por: Kawamura, Takahiko, et al.
Publicado: (2011)

Correlation Between Extracutaneous Microvascular Complications and Diabetic Foot Ulcers in Patients with Type 2 Diabetes Mellitus
por: Balaban, Jagoda, et al.
Publicado: (2020)

Visceral Adiposity Index in Type 2 Diabetes Mellitus (DM) and Its Correlation With Microvascular Complications
por: Hulkoti, Vidyashree, et al.
Publicado: (2022)

The effect of autoimmunity on the development time of microvascular complications in patients with type 1 diabetes mellitus
por: Arslan, Deniz, et al.
Publicado: (2014)

Characteristics of Gut Microbiota in Female Patients with Diabetic Microvascular Complications
por: Gao, Shan, et al.
Publicado: (2022)

Increased Circulating Chemerin in Relation to Chronic Microvascular Complications in Patients with Type 2 Diabetes
por: Gu, Ping, et al.
Publicado: (2019)

Differential correlation between time in range and eGFR or albuminuria in type 2 diabetes
por: Jin, Xuguang, et al.
Publicado: (2023)

Correlations between Glucagon Stimulated C-peptide Levels and Microvascular Complications in Type 2 Diabetes Patients
por: Yoon, Hye-Jin, et al.
Publicado: (2012)

Diabetic Peripheral Microvascular Complications: Relationship to Cognitive Function
por: Ba-Tin, Lorraine, et al.
Publicado: (2011)

Microvascular Complications in Adolescents with Type 1 Diabetes Mellitus
por: Demirel, Fatma, et al.
Publicado: (2013)

Preventing microvascular complications in type 1 diabetes mellitus
por: Viswanathan, Vijay
Publicado: (2015)

Editorial: Cell-Based Therapies for Diabetic Microvascular Complications
por: Bhatwadekar, Ashay D.
Publicado: (2015)

Effects of Incretin-Based Therapies on Diabetic Microvascular Complications
por: Kang, Yu Mi, et al.
Publicado: (2017)

The role of protein oxidation in the development of diabetic microvascular complications
por: Mertoglu, Cuma, et al.
Publicado: (2021)

Determinant of Osteopontin Levels in Microvascular Complications in Patients with Diabetes
por: Nawaz, Shaik Sarfaraz, et al.
Publicado: (2022)

The role of protein kinase C in diabetic microvascular complications
por: Pan, Deng, et al.
Publicado: (2022)

COVID-19 and the hidden threat of diabetic microvascular complications
por: Zaghloul, Hadeel, et al.
Publicado: (2022)

Prospects of stem cell therapy for diabetic microvascular complications
por: Naruse, Keiko
Publicado: (2022)

Cardiovascular Complications of Diabetes: From Microvascular to Macrovascular Pathways
por: Zakir, Mehreen, et al.
Publicado: (2023)

Associations between different bilirubin subtypes and diabetic microvascular complications in middle-aged and elderly individuals
por: Wan, Heng, et al.
Publicado: (2020)

Association of hemoglobin A1c time in range with risk for diabetes complications
por: Mohr, David C, et al.
Publicado: (2022)

Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications
por: Cumbie, Brian C, et al.
Publicado: (2007)

Endothelial Dysfunction and Microvascular Complications in Type 1 Diabetes Mellitus
por: Jin, Seon Mi, et al.
Publicado: (2008)

Diabetic microvascular complications: possible targets for improved macrovascular outcomes
por: D’Elia, John A, et al.
Publicado: (2010)

Retinal Vascular Caliber as a Biomarker for Diabetes Microvascular Complications
por: Ikram, M. Kamran, et al.
Publicado: (2013)

Vitamin D levels and microvascular complications in type 2 diabetes
por: Bajaj, Sarita, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m05oeavig8j32go3pb7lrcr17e